Every stored oracle finding for this trial, including pending, dismissed, rejected, superseded, and accepted items.
NO_DECISIONDismissed100% confidenceGrok 4.20 (xAI)
Will the results be positive?
Trial NCT05907330 is 'Not Yet Recruiting' per ClinicalTrials.gov and multiple sources as of April 2026. No results available; primary completion estimated Feb 2026. Preclinical data exists but no public readout on Phase 2 trial.
Found Apr 6, 2026, 2:58 PMReviewed Apr 6, 2026, 3:00 PM
NO_DECISIONDismissed95% confidenceGrok 4.20 (xAI)
Will the results be positive?
Trial (NCT05907330) is not yet recruiting with primary completion estimated for 2026. No results, topline data, or public readout available. Preclinical papers and sponsor pipeline note only Phase 1 completion for CU104; no efficacy interpretation for this exact Phase 2 UC trial.
Found Apr 6, 2026, 2:09 PMReviewed Apr 6, 2026, 2:19 PM
NO_DECISIONDismissed90% confidencemanual-chat-review
Will the results be positive?
ClinicalTrials.gov still lists this study as unknown with no posted results, so there is not yet a clear public positive or negative trial readout.
Found Apr 4, 2026, 8:54 PMReviewed Apr 4, 2026, 10:32 PM
NO_DECISIONDismissed97% confidenceGPT-5.4 (OpenAI)
Will the results be positive?
No public Phase 2 readout is evident for NCT05907330. ClinicalTrials.gov still shows the study as not yet recruiting with no results posted, and Curacle’s own history lists only Phase 2 IND approvals for CU104, not efficacy data or a trial readout. That is insufficient to call the trial positive or negative.
Found Apr 3, 2026, 4:08 PMReviewed Apr 3, 2026, 4:47 PM
NO_DECISIONDismissed95% confidenceGPT-5.4 (OpenAI)
Will the results be positive?
No trial-specific public efficacy readout was found for NCT05907330. The registry still shows the study as ongoing/without posted results, and company-related reporting in 2024 discussed protocol filing/reapplication and planned start timing rather than topline data. That is insufficient to call the trial positive or negative.
Found Apr 1, 2026, 7:14 PMReviewed Apr 1, 2026, 7:16 PM